Cardiovascular Drugs and Therapy

, Volume 5, Supplement 2, pp 249–268 | Cite as

Oxygen-derived free radicals and myocardial reperfusion injury: An overview

  • Roberto Bolli
Reperfusion Injury: Does It Exist and Can It Be Manipulated?

Summary

Reperfusion of acutely ischemic myocardium is associated with various distinctive pathophysiologic derangements, which are collectively referred to as reperfusion injury. Among these, three have been atributed to oxygen radicals: a) arrhythmias, b) transient mechanical dysfunction (“stunning”), and c) cell death. a) Reperfusion-induced arrhythmias. Although the precise mechanism for reperfusion arrhythmias remains to be determined, considerable evidence suggests that oxygen radicals play an important pathogenetic role in these rhythm disturbances. b) Transient mechanical dysfunction (“myocardial stunning”). Studies suggest that this abnormality is caused by events occurring in the initial seconds of reperfusion, and therefore represents a manifestation of sublethal, reversible reperfusion injury. Although our understanding of the mechanism of myocardial stunning is still fragmentary, there is overwhelming evidence for a pathogenetic role of oxygen radicals. c) Cell death. The evidence that reperfusion causes extension of the infarct produced by the antecedent ischemia is highly controversial. Although several studies have reported reduction of infarct size with antioxidants applied at the time of reperfusion, numerous other investigations have failed to reproduce these results. At present, there is no obvious explanation for this discrepancy. What is clear is that short-term administration of antioxidants at the time of reperfusion will not produce sustained limitation of infarct size. However, the possibility that long-term administration of antioxidants will produce sustained limitation of infarct size merits further consideration. In conclusion, there is strong evidence that the generation of oxygen radicals upon reperfusion plays an important pathogenetic role in two manifestations of reperfusion injury, namely, arrhythmias and stunning. Intense controversy persists regarding whether oxygen radicals contribute to extending cell death upon reperfusion and whether reperfusion in itself causes cell death. On the basis of the evidence available at this time, oxygen radicals appear to be important in the genesis of relatively mild, sublethal forms of myocellular damage, but their role in the genesis of lethal myocellular injury remains to be established.

Key Words

oxygen free radicals coronary reperfusion myocardial ischemia reperfusion arrhythmias myocardial infarction electron paramagnetic resonance spectroscopy spin trapping postischemic dysfunction lipid peroxidation calcium homeostasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jennings RB, Reimer KA. Factors involved in salvaging ischemic myocardium. Effects of reperfusion of arterial blood. Circulation 1983;68(Suppl.):I25-I36.PubMedGoogle Scholar
  2. 2.
    Becker LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987;30:23–44.PubMedCrossRefGoogle Scholar
  3. 3.
    Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: Mechanisms and prevention. J Mol Cell Cardiol 1984;16:497–518.PubMedCrossRefGoogle Scholar
  4. 4.
    Steenbergen C, Murphy E, Levy L, London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 1987;60:700–707.PubMedGoogle Scholar
  5. 5.
    Marban E, Kitakaze M, Kusoka H, et al. Intracellular free calcium concentration measured by 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA 1987;84:6005–6009.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee H-C, Smith N, Mohabir R, Clusin WT. Cytosolic calcium transients from the beating mammalian heart. Proc Natl Acad Sci USA 1987;84:7793–7797.PubMedCrossRefGoogle Scholar
  7. 7.
    Marban E, Koretsune Y, Corretti M et al. Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation 1989;80:(Suppl. IV):IV17-IV22.PubMedGoogle Scholar
  8. 8.
    Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989;80:1049–1062.PubMedGoogle Scholar
  9. 9.
    Manning AS, Coltart DJ, Hearse DJ. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res 1984;55:544–548.Google Scholar
  10. 10.
    Woodward B, Zakaria MVM. Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 1985;17:485–493.PubMedCrossRefGoogle Scholar
  11. 11.
    Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived free radicals: Studies with “anti-free radical” interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986;83:149–151.Google Scholar
  12. 12.
    Riva E, Manning AS, Hearse DJ. Superoxide dismutase and the reduction of reperfusion-induced arrhythmias: In vivo dose-response studies in the rat. Cardiovasc Drugs Ther 1987;1:133–139.PubMedCrossRefGoogle Scholar
  13. 13.
    Manning A, Bernier M, Crome R, et al. Reperfusion-induced arrhythmias: A study of the role of xanthine oxidase-derived free radicals in the rat heart. J Mol Cell Cardiol 1988;20:35–45.PubMedCrossRefGoogle Scholar
  14. 14.
    Hearse DJ, Tosaki A. Free radicals and calcium: Simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart. J Mol Cell Cardiol 1988;20:213–223.PubMedCrossRefGoogle Scholar
  15. 15.
    Kusama Y, Bernier M, Hearse DJ. Singlet oxygen-induced arrhythmias. Dose- and light-response studies for photoactivation of rose bengal in the rat heart. Circulation 1989;80:1432–1448.PubMedGoogle Scholar
  16. 16.
    Heyndrickx GR, Millard RW, McRitchie RJ, et al. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978–985.PubMedCrossRefGoogle Scholar
  17. 17.
    Weiner JM, Apstein CS, Arthur JH, et al. Persistence of myocardial injury following brief periods of coronary occlusion. Cardiovasc Res 1976;10:678–686.PubMedCrossRefGoogle Scholar
  18. 18.
    Theroux P, Ross JJr, Franklin D, et al. Coronary arterial reperfusion. III. Early and late effects on regional myocardial function and dimensions in conscious dogs. Am J Cardiol 1976;38:599–606.PubMedCrossRefGoogle Scholar
  19. 19.
    Heyndrickx GR, Baig H, Nellens P, et al. Depression of regional blood flow and wall thickening after brief coronary occlusions. Am J Physiol 1978;234:H653-H659.PubMedGoogle Scholar
  20. 20.
    Lavallee M, Cox D, Patrick TA, Vatner SF. Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs. Circ Res 1983;53:235–247.PubMedGoogle Scholar
  21. 21.
    Bush LR, Buja LM, Samowitz W, et al. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs: Comparison of 2- and 4-hour occlusions. Circ Res 1983; 53:248–263.PubMedGoogle Scholar
  22. 22.
    Ellis SG, Henschke CI, Sandor T, et al. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1983;1:1047–1055.PubMedGoogle Scholar
  23. 23.
    Matsuzaki M, Gallagher KP, Kemper WS, et al. Sustained regional dysfunction produced by prolonged coronary stenosis: Gradual recovery after reperfusion. Circulation 1983;68:170–182.PubMedGoogle Scholar
  24. 24.
    Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastucture and microvascular damage. Circulation 1983;68(Suppl. I):I8-I15.PubMedGoogle Scholar
  25. 25.
    Bolli R, Zhu WX, Thornby JI, et al. Time-course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol 1988;254:H102-H114.PubMedGoogle Scholar
  26. 26.
    Charlat ML, O'Neill PG, Hartley CJ, et al. Prolonged abnormalities of left ventricular diastolic wall thinning in the “stunned” myocardium in conscious dogs: Time-course and relation to systolic function. J Am Coll Cardiol 1989;13:185–194.PubMedGoogle Scholar
  27. 27.
    Bolli R, Patel BS, Hartley CJ, et al. Nonuniform transmural recovery of contractile function in the “stunned” myocardium. Am J Physiol 1989;257:H375-H385.PubMedGoogle Scholar
  28. 28.
    Braunwald E, Kloner RA. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146–1149.PubMedGoogle Scholar
  29. 29.
    Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial “stunning”: A clinically relevant phenomenon. Ann Intern Med 1988;108:626–628.PubMedGoogle Scholar
  30. 30.
    Zhu WX, Myers ML, Hartley CJ, et al. Validation of a single crystal for measurement of transmural and epicardial thickening. Am J Physiol 1986;251:H1045-H1055.PubMedGoogle Scholar
  31. 31.
    Myers ML, Bolli R, Lekich RF, et al. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 1985;72:915–921.PubMedGoogle Scholar
  32. 32.
    Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the “stunned” myocardium. Circ Res 1986;58:148–156.PubMedGoogle Scholar
  33. 33.
    Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of superoxide dismutase and catalase in “stunned” myocardium of dogs. Am J Physiol 1986;250: H372-H377.PubMedGoogle Scholar
  34. 34.
    Myrry CE, Richard VJ, Jennings RB, Reimer KA. Free radicals do not cause myocardial stunning after four 5 minute coronary occlusions (abstract). Circulation 1989;80 (Suppl. II):II296.Google Scholar
  35. 35.
    Jeroudi MO, Triana FJ, Patel B, Bolli R. Effect of superoxide dismutase and catalase, given separately, on myocardial “stunning”. Am J Physiol 1990;259:H889-H901.PubMedGoogle Scholar
  36. 36.
    Buchwald A, Klein HH, Lindert S, et al. Effect of intracoronary superoxide dismutase on regional function in stunned myocardium. J Cardiovasc Pharmacol 1989;13:258–264.PubMedCrossRefGoogle Scholar
  37. 37.
    Myers ML, Bolli R, Lekich RF, et al. N-2-mercaptopropionyl glycine improves recovery of myocardial function following reversible regional ischemia. J Am Coll Cardiol 1986;8:1161–1168.PubMedGoogle Scholar
  38. 38.
    Fox RB. Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest 1984;74:1456–1464.PubMedCrossRefGoogle Scholar
  39. 39.
    Bolli R, Zhu WX, Hartley CJ, et al. Attenuation of dysfunction in the postischemic “stunned” myocardium by dimenthylthiorea. Circulation 1987;76:458–468.PubMedGoogle Scholar
  40. 40.
    Bolli R, Patel BS, Zhu WX, et al. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 1987;253:H1372-H1380.PubMedGoogle Scholar
  41. 41.
    Farber NE, Vercellotti GM, Jacob HS, et al. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res 1988;63:351–360.PubMedGoogle Scholar
  42. 42.
    Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1–14.PubMedGoogle Scholar
  43. 43.
    Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res 1989;65:607–622.PubMedGoogle Scholar
  44. 44.
    Burton KP, McCord JM, Ghai G. Myocardial alterations due to free-radical generation. Am J Physiol 1984; 246:H776-H783.PubMedGoogle Scholar
  45. 45.
    Blaustein AS, Schine L, Brooks WW, et al. Influence of exogenously generated oxidant species on myocardial function. Am J Physiol 1986;250:H595-H599.PubMedGoogle Scholar
  46. 46.
    Jackson CV, Mickelson JK, Pope TK, et al. O2 free radicalmediated myocardial and vascular dysfunction. Am J Physiol 1986;251:H1225-H1231.PubMedGoogle Scholar
  47. 47.
    Charlat ML, O'Neill PG, Egan JM, et al. Evidence for a pathogenetic role of xanthine oxidase in the “stunned” myocardium. Am J Physiol 1987;252:H566-H577.PubMedGoogle Scholar
  48. 48.
    Puett DW, Forman MB, Cates CU, et al. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation 1987;76:678–686.PubMedGoogle Scholar
  49. 49.
    Holzgrefe HH, Gibson JK. Beneficial effects of oxypurinol pretreatment in stunned, reperfused canine myocardium. Cardiovasc Res 1989;23:340–350.PubMedCrossRefGoogle Scholar
  50. 50.
    Jarasch ED, Bruder G, Heid HW. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand 1986;548(Suppl.):39–46.Google Scholar
  51. 51.
    Eddy LJ, Stewart JR, Jones HP, et al. Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol 1987;253:H709-H711.PubMedGoogle Scholar
  52. 52.
    Muxfeldt M, Schaper W. The activity of xanthine oxidase in hearts of pigs, guinea pigs, rats, and humans. Basic Res Cardiol 1987;82:486–492.PubMedCrossRefGoogle Scholar
  53. 53.
    Huizer T, de Jong JW, Nelson JA, et al. Urate production by human heart. J Mol Cell Cardiol 1989;21:691–695.PubMedCrossRefGoogle Scholar
  54. 54.
    Grum CM, Gallagher KP, Kirsh MM, Shlafer M. Absence of detectable xanthine oxidase in human myocardium. J Mol Cell Cardiol 1989;21:263–267.PubMedCrossRefGoogle Scholar
  55. 55.
    O'Neill PG, Charlat ML, Kim H-S, et al. Lipoxygenase inhibitor nafazatrom fails to attenuate postischemic ventricular dysfunction. Cardiovasc Res 1987;21:755–760.PubMedCrossRefGoogle Scholar
  56. 56.
    O'Neill PG, Charlat ML, Michael LH, et al. Influence of neutrophil depletion on myocardial function and flow after reversible ischemia. Am J Physiol 1989;256:H341-H351.PubMedGoogle Scholar
  57. 57.
    Shea MJ, Simpson PJ, Werns SW, et al. Effect of neutrophil depletion on recovery of “stunned” myocardium (abstract). Clin Res 1987;35:327A.Google Scholar
  58. 58.
    Go LO, Murry CE, Richard VJ, et al. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury. Am J Physiol 1988;255: H1188-H1198.PubMedGoogle Scholar
  59. 59.
    Jeremy RW, Becker LC. Neutrophil depletion does not prevent myocardial dysfunction after brief coronary occlusion. J Am Coll Cardiol 1989:13:1155–1163.PubMedGoogle Scholar
  60. 60.
    Schott RJ, Nao BS, McClanahan TB, et al. F(ab′)2 fragments of anti-mol (904) monoclonal antibodies do not prevent myocardial stunning. Circ Res 1989;65:1112–1124.PubMedGoogle Scholar
  61. 61.
    Kerber RE, Shasby DM, Seabold J, et al. Does reduction of leukocyte accumulation in reperfused myocardium affect stunning? (abstract) Circulation 1989;80(Suppl. II):II401.Google Scholar
  62. 62.
    Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 1987; 110:13–30.PubMedGoogle Scholar
  63. 63.
    Engler R, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 1987;61:20–28.PubMedGoogle Scholar
  64. 64.
    Westlin W, Mullane KM. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation 1989; 80:1828–1836.PubMedGoogle Scholar
  65. 65.
    Bolli R, McCay PB. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: A new approach to assessing the role of oxygen radicals in myocardial “stunning”. Free Rad Res Comms 1990;9:169–180.CrossRefGoogle Scholar
  66. 66.
    Bolli R, Patel BS, Jeroudi MO et al. Demonstration of free radical generation in “stunned” myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 1988;82:476–485.PubMedCrossRefGoogle Scholar
  67. 67.
    Bolli R, Jeroudi MO, Patel BS, et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989;86:4695–4699.PubMedCrossRefGoogle Scholar
  68. 68.
    Romaschin AD, Rebeyka I, Wilson GJ, Mickle DAG. Conjugated dienes in ischemic and reperfused myocardium: An in vivo chemical signature of oxygen free radical mediated injury. J Mol Cell Cardiol 1987;19:289–302.PubMedCrossRefGoogle Scholar
  69. 69.
    Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavening free radicals? Circulation 1988;77(Suppl. I):I30-I39.PubMedGoogle Scholar
  70. 70.
    Triana JF, Unisa A, Bolli R. Antioxidant enzymes attenuate myocardial “stunning” in the conscious dog (abstract). FASEB J 1990;4:A622.Google Scholar
  71. 71.
    Thompson JA, Hess ML. The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis 1986;28:449–462.PubMedCrossRefGoogle Scholar
  72. 72.
    McCay PB, Lai EK, Poyer JL, et al. Oxygen- and carbon-centered free radical formation during carbon tetrachloride metabolism. J Biol Chem 1984;259:2135–2142.PubMedGoogle Scholar
  73. 73.
    Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987; 84:1404–1407.PubMedCrossRefGoogle Scholar
  74. 74.
    Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61:757–760.PubMedGoogle Scholar
  75. 75.
    Baker JE, Felix CC, Olinger GN, Kalyanaraman B. Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci USA 1988;85:2786–2789.PubMedCrossRefGoogle Scholar
  76. 76.
    Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. J Biol Chem 1988;263: 1353–1357.PubMedGoogle Scholar
  77. 77.
    Shattock MJ, Manning AS, Hearse DJ. Effects of hydrogen peroxide on cardiac function and postischemic functional recovery in the isolated “working” rat heart. Pharmacology 1982;24:118–122.PubMedCrossRefGoogle Scholar
  78. 78.
    Ytrehus K, Myklebust R, Mjos OD. Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart. Cardiovasc Res 1986;20:597–603.PubMedCrossRefGoogle Scholar
  79. 79.
    Schrier GM, Hess ML. Quantitative identification of superoxide anion as a negative inotropic species. Am J Physiol 1988;24:H138-H143.Google Scholar
  80. 80.
    Goldhaber JI, Ji S, Lamp ST, Weiss JN. Effects of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricle: Implications for ischemia and reperfusion injury. J Clin Invest 1988;83:1800–1809.CrossRefGoogle Scholar
  81. 81.
    Miki S, Ashraf M, Salka S, Sperelakis N. Myocardial dysfunction and ultrastructural alterations mediated by oxygen metabolites. J Mol Cell Cardiol 1988;20:1009–1024.PubMedCrossRefGoogle Scholar
  82. 82.
    Przyklenk K, Whittaker P, Kloner RA. In vivo infusion of oxygen free radical substrates causes myocardial systolic, but not diastolic dysfunction. Am Heart J 1990;119: 807–815.PubMedCrossRefGoogle Scholar
  83. 83.
    Davies KJA. Protein damage and degradation by oxygen radicals. I. General aspects. J Biol Chem 1987;262: 9895–9901.PubMedGoogle Scholar
  84. 84.
    Weisel RD, Mickle DAG, Finkle CD, et al. Myocardial free-radical injury after cardioplegia. Circulation 1989; 80(Suppl. III):III14-III18.PubMedGoogle Scholar
  85. 85.
    Krause SM, Jacobus WE, Becker LC. Alterations in cardiac sarcoplasmic reticulum calcium transport in the post-ischemic “stunned” myocardium. Circ Res 1989;65:526–530.PubMedGoogle Scholar
  86. 86.
    Rowe GT, Manson NH, Caplan M, Hess ML. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum: Participation of the cyclooxygenase pathway. Circ Res 1983;53: 584–591.PubMedGoogle Scholar
  87. 87.
    Kramer JH, Mak IT, Weglicki WB. Differential sensitivity of canine cardiac sarcolemmal and microsomal enzymes to inhibition by free radical-induced lipid peroxidation. Circ Res 1984;55:120–124.PubMedGoogle Scholar
  88. 88.
    Reeves JP, Bailey CA, Hale CC. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem 1986;261:4948–4955.PubMedGoogle Scholar
  89. 89.
    Kim M-S, Akera T. O2 free radicals: Cause of ischemia-reperfusion injury to cardiac Na+−K+-ATPase. Am J Physiol 1987;252:H252-H257.PubMedGoogle Scholar
  90. 90.
    Kaneko M, Beamish RE, Dhalla NS. Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol 1989;256:H368-H374.PubMedGoogle Scholar
  91. 91.
    Stewart JR, Blackwell WH, Crute SL, et al. Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers. J Thorac Cardiovasc Surg 1983;86:262–272.PubMedGoogle Scholar
  92. 92.
    Johnson DL, Horneffer PJ, Dinatale JMJr. et al. Free radical scavengers improve functional recovery of stunned myocardium in a model of surgical coronary revascularization. Surgery 1987;102:334–340.PubMedGoogle Scholar
  93. 93.
    Gardner TJ: Oxygen radicals in cardiac surgery. Free Rad Biol Med 1988;4:45–50.PubMedCrossRefGoogle Scholar
  94. 94.
    Illes RW, Silverman NA, Krukenkamp IB, et al. Amelioration of postischemic stunning by deferoxamine-blood cardioplegia. Circulation 1989;80(Suppl. III):III30-III35.PubMedGoogle Scholar
  95. 95.
    Shlafer M, Kane PF, Kirsh MM. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 1982;83:830–839.PubMedGoogle Scholar
  96. 96.
    Shlafer M, Kane PF, Wiggins VY, Kirsh MM. Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury. Circulation 1982;66(Suppl. I):I85-I92.PubMedGoogle Scholar
  97. 97.
    Casale AS, Bulkley GB, Bulkley BH, Flaherty JT, et al. Oxygen free radical scavengers protect the arrested globally ischemic heart upon reperfusion. Surg Forum 1983;34:313–316.Google Scholar
  98. 98.
    Menasche P, Grousset C, Gauduel Y, Piwnica A. A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase. J Thorac Cardiovasc Surg 1986;92:264–271.PubMedGoogle Scholar
  99. 99.
    Myers CL, Weiss SJ, Kirsh MM, et al. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts. J Thorac Cardiovasc Surg 1986;91:281–289.PubMedGoogle Scholar
  100. 100.
    Ambrosio G, Weisfeldt ML, Jacobus WE, et al. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: Reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 1987;75:282–291.PubMedGoogle Scholar
  101. 101.
    Ytrehus K, Gunnes S, Myklebust R, Mjos OD. Protection by superoxide dismutase and catalase in the isolated rat heart reperfused after prolonged cardioplegia: A combined study of metabolic, functional, and morphometric ultrastructural variables. Cardiovasc Res 1987;21:492–499.PubMedCrossRefGoogle Scholar
  102. 102.
    Vanhaecke J, Van de Werf F, Jang I-K, et al. Despite superoxide dismutase treatment, postischemic contractile dysfuntion persists after 4 hours of reperfusion (abstract). J Am Coll Cardiol 1988;11:164A.Google Scholar
  103. 103.
    Patel BS, Jeroudi MO, O'Neill PG, et al. Effect of human recombinant superoxide dismutase on canine myocardial infarction. Am J Physiol 1990;258:H369-H380.PubMedGoogle Scholar
  104. 104.
    Asinger RW, Peterson DA, Elsperger KJ, Homans D. Long-term recovery of LV wall thickening after 1 hour of ischemia is not affected when superoxide dismutase and catalase are administered during the first 45 minutes of reperfusion (abstract). J Am Coll Cardiol 1988;2:163A.Google Scholar
  105. 105.
    Nejima J, Knight DR, Fallon JT, et al. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional myocardial function or myocardium at risk in conscious dogs. Circulation 1989;79:143–153.PubMedGoogle Scholar
  106. 106.
    Przyklenk K, Kloner RA. “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 1989; 64:86–96.PubMedGoogle Scholar
  107. 107.
    Forman MB, Puett DW, Cates CU, et al. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function. Circulation 1988;78:202–213.PubMedGoogle Scholar
  108. 108.
    Przyklenk K, Kloner RA. Effect of verapamil on postischemic “stunned” myocardium: Importance of the timing of treatment. J Am Coll Cardiol 1988;11:614–623.PubMedCrossRefGoogle Scholar
  109. 109.
    Lamping KA, Gross GJ. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol 1985;7:158–166.PubMedCrossRefGoogle Scholar
  110. 110.
    Bush LR, Buja LM, Tilton G, et al. Effect of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. Circulation 1985;72:413–430.PubMedGoogle Scholar
  111. 111.
    Tilton GD, Bush LR, Apprill PG, et al. Effect of diltiazem and propranolol on left ventricular segmental relaxation in conscious dogs. Circulation 1985;71:165–175.PubMedGoogle Scholar
  112. 112.
    Taylor AL, Golino P, Eckels R, et al. Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 1990;15:737–747.PubMedGoogle Scholar
  113. 113.
    Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic “stunned” myocardium. J Am Coll Cardiol 1989;13:1176–1183.PubMedGoogle Scholar
  114. 114.
    Ito BR, Tate H, Kobayashi M, Schaper W. Reversibly injured, postischemic canine myocardium retains normal contractile reserve. Cric Res 1987;61:834–846.Google Scholar
  115. 115.
    Kusuoka H, Porterfield JK, Weisman HF, et al. Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 1987;79:950–961.PubMedCrossRefGoogle Scholar
  116. 116.
    Kitakaze M, Weisman HF, Marban E. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts. Circulation 1988;77:685–695.PubMedGoogle Scholar
  117. 117.
    Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest 1988;82:920–927.PubMedCrossRefGoogle Scholar
  118. 118.
    Hori M, Kitakaze M, Sato H, et al. Transient acidosis by staged reperfusion prevents myocardial stunning (abstract). Circulation 1989;80(Suppl. II):II600.Google Scholar
  119. 119.
    Guarnieri T. Direct measurement of [Ca2+]i in early and late reperfused myocardium (abstract). Circulation 1989; 80(Suppl. II):II-241.Google Scholar
  120. 120.
    Kusuoka H, Koretsune Y, Chacko VP, et al. Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? Circ Res 1990;66:1268–1276.PubMedGoogle Scholar
  121. 121.
    Becker LC, Levine JH, DiPaula AF, et al. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 1986;7:580–589.PubMedGoogle Scholar
  122. 122.
    Heusch G, Schafer S, Kroger K. Recruitment of inotropic reserve in “stunned” myocardium by the cardiotonic agent AR-L 57. Basic Res Cardiol 1988;83:602–610.PubMedCrossRefGoogle Scholar
  123. 123.
    Hearse DJ, Humphrey SM, Bullock GR. The oxygen paradox and the calcium paradox: Two facets of the same problem? J Mol Cell Cardiol 1978;10:641–668.PubMedCrossRefGoogle Scholar
  124. 124.
    Lazdunski M, Frelin C, Vigue P. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029–1042.PubMedCrossRefGoogle Scholar
  125. 125.
    Tani M, Neely JR. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+−Na+ and Na+−Ca2+ exchange. Circ Res 1989;65:1045–1056.PubMedGoogle Scholar
  126. 126.
    Murphy JG, Smith TW, Marsh JD. Mechanisms of reoxygenation-induced calcium overload in cultured chick embryo heart cells. Am J Physiol 1988;254:H1133-H1141.PubMedGoogle Scholar
  127. 127.
    McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159–163.PubMedGoogle Scholar
  128. 128.
    Engler R, Gilpin E. Can superoxide dismutase alter myocardial infarct size? Circulation 1989;79:1137–1142.PubMedGoogle Scholar
  129. 129.
    Jolly SR, Kane WJ, Bailie MB, et al. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984;54:277–285.PubMedGoogle Scholar
  130. 130.
    Chambers DE, Parks DA, Patterson G, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145–152.PubMedCrossRefGoogle Scholar
  131. 131.
    Werns SW, Shea MJ, Driscoll EM, et al. The independent effects of oxygen radical scavengers on canine infarct size: Reduction by superoxide dismutase but not catalase. Circ Res 1985;56:895–898.PubMedGoogle Scholar
  132. 132.
    Ambrosio G, Becker LC, Hutchins GM, et al. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insights into the pathophysiology of reperfusion injury. Circulation 1986;74:1424–1433.PubMedGoogle Scholar
  133. 133.
    Naslund U, Haggmark S, Johansson G, et al. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model. J Mol Cell Cardiol 1986;18:1077–1084.PubMedCrossRefGoogle Scholar
  134. 134.
    Gallagher KP, Buda AJ, pace D, et al. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation 1986;73:1065–1076.PubMedGoogle Scholar
  135. 135.
    Uraizee A, Reimer KA, Murray CE, Jennings RB. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987;75:1237–1248.PubMedGoogle Scholar
  136. 136.
    Werns SW, Simpson PJ, Mickelson JK, et al. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J Cardiovasc Pharmacol 1988;11:36–44.PubMedCrossRefGoogle Scholar
  137. 137.
    Przyklenk K, Kloner RA. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: Salvage or delay of myocyte necrosis? Basic Res Cardiol 1987;82:146–158.PubMedCrossRefGoogle Scholar
  138. 138.
    Limm WM, Mugiishi MM, Schwartz SM, McNamara JJ. Oxygen free radical scavengers do not reduce infarct size in baboons (abstract). J Am Coll Cardiol 1988;II:163A.Google Scholar
  139. 139.
    Matsuda M, Fujiwara H, Onodera T, et al. Failure to reduce infarct size by intracoronary infusion of human superoxide dismutase at reperfusion in the pig heart: Immuno-histochemical and histological analysis (abstract). Circulation 1988;78(Suppl. II):II372.Google Scholar
  140. 140.
    Shirato C, Miura T, Downey JM. Superoxide dismutase (single dose) delays rather than prevents necrosis in reperfused rabbit heart (abstract). FASEB J 1988;2:A918.Google Scholar
  141. 141.
    Tamura Y, Chi L, Driscoll EMJr., et al. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res 1988;63:944–959.PubMedGoogle Scholar
  142. 142.
    Richard VJ, Murry CE, Jennings RB, Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation 1988;78:473–480.PubMedGoogle Scholar
  143. 143.
    Chi L, Tamura Y, Hoff PT, et al. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: A demonstration of myocardial salvage. Circ Res 1989;64: 665–675.PubMedGoogle Scholar
  144. 144.
    Kinsman JM, Murry CE, Richard VJ, et al. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion. J Am Coll Cardiol 1988;12:209–217.PubMedGoogle Scholar
  145. 145.
    Werns SW, Shea MJ, Mitsos SE, et al. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation 1986;73:518–524.PubMedGoogle Scholar
  146. 146.
    Reddy BR, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischemia/reperfusion injury. Free Rad Biol Med 1989;7:45–52.PubMedCrossRefGoogle Scholar
  147. 147.
    Lesnefsky EJ, Dauber I, Coller H, Horwitz LD. Deferoxamine, an iron chelator, reduces canine infarct size (abstract). Circulation 1988;78:II372.Google Scholar
  148. 148.
    Reimer KA, Jennings RB. Failure of xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 1985;71:1069–1075.PubMedGoogle Scholar
  149. 149.
    Werns SW, Ventura A, Hahn RA, Lucchesi BR. Effects of two xanthine oxidase inhibitors, amflutizole and oxypurinol, on canine myocardial infarction (abstract). FASEB J 1989;3:A1021.Google Scholar
  150. 150.
    Richard VJ, Murry CE, Jennings RB, Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation 1988;78:473–480.PubMedGoogle Scholar
  151. 151.
    Mitsos SE, Fantone JC, Gallagher KP, et al. Canine myocardial reperfusion injury: Protection by a free radical scavenger, N-2-mercaptopropionyl glycine. J Cardiovasc Pharmacol 1986;8:978–988.PubMedCrossRefGoogle Scholar
  152. 152.
    Klein HH, Pich S, Lindert S, et al. Intracoronary superoxide dismutase for the treatment of “reperfusion injury”. A blind randomized placebo-controlled trial in ischemic, reperfused porcine hearts. Basic Res Cardiol 1988;83: 141–148.PubMedCrossRefGoogle Scholar
  153. 153.
    Matsuki T, Shirato C, Cohen MV, Downey JM. Oxypurinol and allopurinol reduce infarct size in reperfused dogs heart without pretreatment (abstract). The Physiologist 1987; 30:187.Google Scholar
  154. 154.
    Naslund U, Haggmark S, Johansson G, et al. Limitation of myocardial infarct size by superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig. Circ Res 1990;66:1294–1301.PubMedGoogle Scholar
  155. 155.
    Jugdutt B, Wang S, Demare J, Lui T, et al. Preservation of myocardial function and topography by late reperfusion and superoxide dismutase therapy (abstract). J Am Coll Cardiol 1989;13:109A.Google Scholar
  156. 156.
    Miura T, Yellon DM, Kingma JG, Downey JM. Protection afforded by allopurinol in the first 24 hours of occlusion is diminished after 48 hours. Free Rad Biol Med 1988;4:25–30.PubMedCrossRefGoogle Scholar
  157. 157.
    Kingma JG, Denniss AR, Hearse DJ, et al. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog. Circulation 1987;75(Suppl. V):V25-V33.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1991

Authors and Affiliations

  • Roberto Bolli
    • 1
  1. 1.Experimental Animal Laboratory, Section of Cardiology, Department of MedicineBaylor College of MedicineHoustonUSA

Personalised recommendations